Sabril Articles

Catalyst Pharma shares fall after mid-stage cocaine addiction trial delayed

27 September 2012

Lundbeck gains US approval for Sabril

24 August 2009

Denmark's Lundbeck to buy Ovation for $900M

16 February 2009

Ovation's Sabril recommended for epilepsy

19 January 2009

Anti-addiction drug may treat obesity

1 September 2008

FDA earmarks Sabril for fast-track review

4 February 2008

Japanese study group urges Zolinza appro

7 May 2007

Ovation gains two CNS drugs from Aventis

19 April 2004

Higher-Priced Drugs Set To Expand Epilepsy Market

12 February 1996

USA Lags Foreign Approvals, PhRMA Demonstrates

16 October 1995

Communication Gap In Epilepsy Management In UK?

8 May 1995

....And Marion Merrell Dow Updates On R&D Efforts

10 April 1995

Hoechst Offers $7 Billion For Marion Merrell Dow

6 March 1995

Vigabatrin NDA Filed In The USA

18 July 1994

LAMICTAL APPROVED FOR PEDIATRIC USE

23 May 1994

SANDOZ AND MMD IN COPROMOTION

28 February 1994

THE DAWN OF A NEW ERA FOR EPILEPSY

27 September 1993

NEW HOPES FOR EPILEPSY TREATMENT

12 July 1993

1991 A "SUPERB" YEAR FOR MARION MERRELL DOW

13 April 1992

Showing 1-19 of 19 articles

Go to beginningPrevious
  • 1
NextGo to end